NIR-II reinforced intracellular cyclic reaction to enhance chemodynamic therapy with abundant H<sub>2</sub>O<sub>2</sub> supply.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34153782.
- Also identified by DOI 10.1016/j.biomaterials.2021.120962.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemodynamic therapy (CDT) is an ideal therapeutic modality with endogenous H<sub>2</sub>O<sub>2</sub> as stimulus. Most intracellular H<sub>2</sub>O<sub>2</sub> supplement strategies for improving CDT efficiency are strongly rely on oxygen participation, and the hypoxia tumor microenvironment impairs their performance. Here we develop a self-assembled metal-organic coordinated nanoparticle Cu-OCNP/Lap with NIR-II reinforced intracellular cyclic reaction to enhance CDT efficiency. Cu-OCNP/Lap is synthesized using Cu<sup>2+</sup> as nodes and 1,4,5,8-tetrahydroxyanthraquinone (THQ) and banoxantrone dihydrochloride (AQ4N) as ligands, with β-lapachone (β-Lap) loading to conduct intracellular cyclic reaction. Cu-OCNP/Lap has good photothermal effect at NIR-II window, and the corresponding local temperature increase speeds blood flow and supplies sufficient oxygen at tumor site to reinforce β-Lap cyclic reaction with abundant H<sub>2</sub>O<sub>2</sub> generation. Cu<sup>+</sup> is released from Cu-OCNP/Lap in response to glutathione (GSH) and triggers CDT. Sufficient intracellular H<sub>2</sub>O<sub>2</sub> supply enhances CDT effect and demonstrates good suppressions for tumor growth. This design offers a promising strategy to enhance CDT efficiency.
Medical subject headings
- Metal Nanoparticles
- Nanoparticles
- Neoplasms